A deep dive into the Fc–FcR axis as a therapeutic anchor in autoimmune disease, examining immune signaling and drug ...

The Pensions Regulator regulatory theme lead for administration, dashboards and cyber Taylor Brightwell-Smith will provide an ...

Learn how pH-sensitive dye detection supports reliable ADC internalization assays and insight into cellular uptake mechanisms ...

Danish biotech startup Bactolife has raised €30M ($35M) to launch its precision-fermented binding proteins in the US to boost ...

A sensor that requires no nanoscale patterning detects single molecules of a breast cancer protein at concentrations 250 ...

Considering a switch from IVIg to SCIg for primary immunodeficiency? Explore differences in responsibility, side effects, ...

Adimab's latest partner program to receive approval is GSK's Exdensur (depemokimab), approved in the US for the treatment of severe asthma with an eosinophilic phenotype and in the UK and Japan for ...

Coherus Oncology, Inc. ( CHRS) 44th Annual J.P. Morgan Healthcare Conference January 13, 2026 1:30 PM EST Good morning everyone. It's still the morning. Thanks for joining us for another session at ...

CD BioGlyco leverages its state-of-the-art platform and years of experience to deliver precise and consistent modifications to your antibody glycans. Researchers can now access homogeneous glycoforms ...

M&G Plc ( (GB:MNG)) has issued an announcement. M&G plc has confirmed that, as at 31 December 2025, its issued share capital consisted of 2,412,524,010 ordinary shares of 5 pence each, of which ...